Zhe Wan

Sir Run Run Shaw Hospital, 3 East Qingchun Road
Hangzhou, 310016, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications

Amino acid substitutions at the G118 hotspot in dihydroorotate dehydrogenase confer olorofim resistance in Aspergillus flavus.

Amino acid substitutions at the G118 hotspot in dihydroorotate dehydrogenase confer olorofim resistance in Aspergillus flavus.

Journal: Microbiology spectrum
Published: July 14, 2026

Dynamic shifts in cutaneous bacterial and fungal communities throughout human aging: a pilot study.

Dynamic shifts in cutaneous bacterial and fungal communities throughout human aging: a pilot study.

Journal: BMC microbiology
Published: January 13, 2026

Single-cell RNA sequencing unravels T cell exhaustion underlying the chronicity of chromoblastomycosis.

Single-cell RNA sequencing unravels T cell exhaustion underlying the chronicity of chromoblastomycosis.

Journal: Frontiers in immunology
Published: January 09, 2026

Genome analysis and machine learning-based feature selection strategy reveal potential drug-resistance determinants in Nakaseomyces glabratus.

Genome analysis and machine learning-based feature selection strategy reveal potential drug-resistance determinants in Nakaseomyces glabratus.

Journal: Emerging microbes & infections
Published: November 27, 2025

Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability.

Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability.

Journal: Antimicrobial agents and chemotherapy
Published: October 10, 2025

Dual epitope anti-LILRB4 synthetic T-cell receptor and antigen receptor (STAR)-T-cell therapy for relapsed/refractory acute myeloid leukemia.

Dual epitope anti-LILRB4 synthetic T-cell receptor and antigen receptor (STAR)-T-cell therapy for relapsed/refractory acute myeloid leukemia.

Journal: Signal transduction and targeted therapy
Published: September 28, 2025

Antifungal susceptibility surveillance of clinical moulds to olorofim, manogepix, amphotericin B, triazoles and echinocandins at 10 tertiary hospitals in China (2019-24).

Antifungal susceptibility surveillance of clinical moulds to olorofim, manogepix, amphotericin B, triazoles and echinocandins at 10 tertiary hospitals in China (2019-24).

Journal: The Journal of antimicrobial chemotherapy
Published: July 29, 2025

The Effect of Topical Ketoconazole and Topical Miconazole Nitrate in Modulating the Skin Microbiome and Mycobiome of Patients With Tinea Pedis.

The Effect of Topical Ketoconazole and Topical Miconazole Nitrate in Modulating the Skin Microbiome and Mycobiome of Patients With Tinea Pedis.

Journal: Mycoses
Published: May 25, 2025

Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial.

Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial.

Journal: Nature medicine
Published: April 21, 2025

Safety and feasibility of the KONO-S anastomosis technique with biodegradable stent in Crohn's disease: a pilot study.

Safety and feasibility of the KONO-S anastomosis technique with biodegradable stent in Crohn's disease: a pilot study.

Journal: International journal of colorectal disease
Published: April 05, 2025

Emerging antifungal resistance in Trichophyton mentagrophytes: insights from susceptibility profiling and genetic mutation analysis.

Emerging antifungal resistance in Trichophyton mentagrophytes: insights from susceptibility profiling and genetic mutation analysis.

Journal: Emerging microbes & infections
Published: January 03, 2025

Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis.

Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis.

Journal: The British journal of dermatology
Published: January 03, 2025
Showing 1-12 of 98

Last Updated: 09/26/2026